1xbet 모바일s
News Releases
2017
December
1xbet 모바일s
1xbet 모바일 to Invest in Megakaryon Corporation, with the Aim to Advance Commercialization of iPS-cell-derived Platelet Preparations
1xbet 모바일s
1xbet 모바일 and X-Chem Enter into a Drug Discovery Research and License Collaboration(PDF: 119.0 KB)
Nutraceuticals
1xbet 모바일 Establishes Joint Research Chair for Women's Health Promotion with Hirosaki University Graduate School of Medicine
1xbet 모바일s
1xbet 모바일 Co., Ltd. Receives the Japan Medical R&D Grand Prize for Development of Delamanid, a Drug for Multidrug-resistant Tuberculosis Japanese Government Grants Award for the First Time
Corporate
1xbet 모바일 Unveils It's Completely New Website
Corporate
1xbet 모바일 Receives Newly Established "Sports Yell Company" Certification from Japan Sports Agency
Nutraceuticals
Observational study of 88 female K1xbet 모바일dai University athletes Relationship between premenstrual syndrome-1xbet 모바일duced 1xbet 모바일terference 1xbet 모바일 athletic performance and equol production status
November
1xbet 모바일s
1xbet 모바일 to Launch New, Pre-mixed Flavor Formulations (Fruit and Coffee) for Aminoleban EN, an Oral Nutritional Supplement for Patients with Liver Failure
1xbet 모바일s
1xbet 모바일 Launches New Formulations in Japan of L-Cartin® for Carnitine Deficiencies
Nutraceuticals
1xbet 모바일 Enters Into Comprehensive Regional Revitalization Partnership Agreement with Yamaguchi Prefecture
Corporate
1xbet 모바일 Cooperates with Community Health Promotion EffortsTokushima Itano Factory Sponsors "Asan Walking Festa in Itano"
Nutraceuticals
1xbet 모바일 to Become a Sponsor of the 18th Asian Games
1xbet 모바일s
1xbet 모바일 and Proteus Announce the First U.S. FDA Approval of a Digital Medicine System: ABILIFY MYCITE® (aripiprazole tablets with sensor)
1xbet 모바일s
U.S. FDA Accepts 1xbet 모바일's Resubmission to Support a Regulatory Review of Tolvaptan in the Treatment of ADPKD
Nutraceuticals
1xbet 모바일 Enters into Comprehensive Cooperative Partnership with Oita Prefecture
1xbet 모바일s
1xbet 모바일 Announces Phase 3 Results for Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Corporate
1xbet 모바일 Tokushima Wajiki Factory Receives2017 Minister of Economy, Trade and Industry Award for Excellent Greening, a First for the Shikoku Region
1xbet 모바일s
1xbet 모바일 and Lundbeck will Initiate a Third Phase 3 Trial to Evaluate Brexpiprazole in the Treatment of Agitation in Patients with Dementia of the Alzheimer's Type
October
Nutraceuticals
US Launch of EQUELLE, a Dietary Supplement to Support Women's Health
Nutraceuticals
Heat Disorders Prevention - Communication Project "Hitosuzumi Awards 2017"1xbet 모바일 Recognized with "Team Excellence" and "Top Runner" Awards
1xbet 모바일s
1xbet 모바일 Submits a Japan NDA for Nalmefene, a Drug to Reduce Alcohol Consumption in Alcohol-Dependent Patients
1xbet 모바일s
1xbet 모바일 and Lundbeck Announce Initiation of Two Phase 3 Trials of Brexpiprazole in Patients with Bipolar I Disorder
Nutraceuticals
1xbet 모바일 Enters into Comprehensive Partnership with Kochi Prefecture
August
1xbet 모바일s
1xbet 모바일 and Mylan Announce License Agreement to Commercialize Delamanid (DeltybaTM) for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries(PDF: 467.1 KB)
Nutraceuticals
Extremely F1xbet 모바일e-textured Foam Facial Cleanser 1xbet 모바일troduc1xbet 모바일g UL·OS Face Wash for Sk1xbet 모바일 Care Evolution of Face Wash from "Cleans1xbet 모바일g" to "Sk1xbet 모바일 Care"
Corporate
1xbet 모바일 Participates in Summer Events in Tokushima Exciting Summer in WAJIKI, Tokushima Awa Odori, Oronamin C Drink Presents Awa Odori Sound Festival
July
1xbet 모바일s
ABILIFY MA1xbet 모바일TENA® (aripiprazole) for Extended-Release 1xbet 모바일jectable Suspension Approved by U.S. FDA for Ma1xbet 모바일tenance Monotherapy Treatment of Bipolar I Disorder
1xbet 모바일s
1xbet 모바일 Submits New Drug Application in Japan for Aripiprazole Sertraline Combination Tablets
Nutraceuticals
1xbet 모바일 to Acquire Daiya, a Rapidly Growing Plant-Based Food Company in North America
Nutraceuticals
1xbet 모바일 Serves as Special Sponsor of Summer Inter-High School Athletic Meeting for Fourth Consecutive Year Event Venue Enlivened with Heat Stroke Prevention Posters and Banners Submitted by Local High School Students
1xbet 모바일s
"Quick Navi-Flu2" 1xbet 모바일fluenza Diagnostic Kit to Launch 1xbet 모바일 Japan
Nutraceuticals
1xbet 모바일 Enters into Partnership Agreement with Wakayama Prefecture
Nutraceuticals
1xbet 모바일 Establishes New Functional Food and Beverage Affiliate in Thailand
1xbet 모바일s
1xbet 모바일 and R-Pharm Announce Licensing Agreement to Commercialize DeltybaTM (Delamanid) for Multidrug-Resistant Tuberculosis (MDR-TB) in Russia and CIS Countries(PDF: 99.9 KB)
1xbet 모바일s
Smart Medic1xbet 모바일e Conta1xbet 모바일er for Anti-stroke Medic1xbet 모바일e Approved for Sale 1xbet 모바일 Japan
June
1xbet 모바일s
Quick NaviTM-Mycoplasma Diagnostic Kit to Launch 1xbet 모바일 Japan
1xbet 모바일s
Nalmefene, a Drug Candidate to Reduce Alcohol Consumption, Shows Positive Results from Phase III Trial 1xbet 모바일 Japan
1xbet 모바일s
1xbet 모바일 to Continue Commitment to Support the Global Health Innovative Technology Fund (GHIT Fund)
May
1xbet 모바일s
Additional Formulation of Samsca®Granules 1% Available 1xbet 모바일 Japan
Nutraceuticals
Kenja-no-Kaim1xbet 모바일 Sleep Rhythm Support Asparagus-derived 1xbet 모바일gredient improves sleep-wake rhythms and enhances quality of sleep
1xbet 모바일s
1xbet 모바일 and Proteus Digital Heath Resubmit Application to US FDA for First Digital Medicine
1xbet 모바일s
1xbet 모바일 Announces Results of Phase 3 Data on Tolvaptan Under Development for ADPKD in U.S.
Corporate
1xbet 모바일 Announces Construction of New Pharmaceutical Manufacturing Facility, Tokushima Mima Factory
Corporate
1xbet 모바일 Agree to Purchase New Share Allocation of TWO CELLS
1xbet 모바일s
1xbet 모바일 and Teva Sign Licensing Agreement for Japan on Prophylactic Migraine Drug Candidate Fremanezumab (TEV-48125)
Corporate
Nutrition & Santé 1xbet 모바일augurates New Gluten-Free Manufactur1xbet 모바일g Facility
1xbet 모바일s
1xbet 모바일 and Lundbeck Announce Results of Brexpiprazole on Symptoms of Agitation Related to Alzheimer's-type Dementia
April
1xbet 모바일s
1xbet 모바일 and Akebia Concludes Licensing Agreement for Akebia's Renal Anemia Drug Vadadustat - Development and marketing territories include Europe, China, etc. -
Nutraceuticals
Renewal of Fibe-M1xbet 모바일i Dietary Fiber Beverage Food for Specified Health Uses Now Conta1xbet 모바일s Lycopene - Renewal Launch with New Package and Logo Design -
Nutraceuticals
Am1xbet 모바일o-Value 4000 and Am1xbet 모바일o-Value Powder 8000 Renewed as Foods with Function Claim "Alleviates Fatigue Caused by Physical Activity"
Nutraceuticals
1xbet 모바일 Introduces New BODYMAINTÉ Brand BODYMAINTÉ Jelly, a conditioning food to be launched in April 2017
March
Nutraceuticals
1xbet 모바일 Enters into Health-related Partnership with Fukui Prefecture
Nutraceuticals
1xbet 모바일 Enters into Comprehensive Partnership Agreement with Ibaraki Prefecture
1xbet 모바일s
Lundbeck and 1xbet 모바일's Brexpiprazole for Adult Patients with Schizophrenia Accepted for Review by EMA
1xbet 모바일s
Ribociclib (LEE011) Receives Regulatory Approval 1xbet 모바일 U.S. as a First-L1xbet 모바일e Treatment for HR+/HER2- Advanced Breast Cancer with an aromatase 1xbet 모바일hibitor
1xbet 모바일s
Approval for the Additional Formulation of Samsca®Granules 1% 1xbet 모바일 Japan
Corporate
1xbet 모바일 Appoints Board Members and Statutory Auditors(PDF: 56.1 KB)
1xbet 모바일s
1xbet 모바일 Supports "Light-Up in Green" Glaucoma Awareness Activities
1xbet 모바일s
1xbet 모바일 to Acquire Neurovance, Inc. Acquisition of clinical-stage company in ADHD widens Otsuka's presence in mental health
February
Nutraceuticals
New Addition to Gerblé L1xbet 모바일e of Nutritional Food Products from Southern France - Prune & Fig Biscuits -
Nutraceuticals
1xbet 모바일 Enters into Comprehensive Cooperative Agreement with Tochigi Prefecture
Corporate
1xbet 모바일 Certified as Excellent Health and Productivity Management Enterprise
Nutraceuticals
1xbet 모바일 Introduces New BODYMAINTÉ Brand BODYMAINTÉ Jelly, a conditioning food to support athletic performance to be launched in April 2017
Nutraceuticals
1xbet 모바일 LaunchesOATHASTra1xbet 모바일1xbet 모바일g Program for Healthy Ag1xbet 모바일g Supporters Program to support pharmacies as health 1xbet 모바일formation bases with strong connections to local community
1xbet 모바일s
Health Canada Approves 1xbet 모바일 and Lundbeck's REXULTI (brexpiprazole) as a Treatment for Schizophrenia in Adults
Nutraceuticals
1xbet 모바일 Supports Tokyo Marathon 2017 as Official Partner Providing comprehensive support for runners' conditioning for the 11th consecutive year
1xbet 모바일s
Osaka University and 1xbet 모바일 Agree Comprehensive Collaboration : Joint Research Project with Immunology Frontier Research Center (IFReC)(PDF: 226.3 KB)
Nutraceuticals
1xbet 모바일 Enters into Comprehensive Partnership with Okinawa Prefecture
Nutraceuticals
1xbet 모바일 Enters into Comprehensive Health-related Agreement with Aichi Prefecture
Nutraceuticals
1xbet 모바일 Enters into Health Promotion and Disaster Relief Supply Agreements with Kagawa Prefecture
Nutraceuticals
1xbet 모바일troduc1xbet 모바일g New SOYJOY Crispy White Macadamia Crunchy soy nutrition bar flavored with soy-based white chocolate and macadamia nuts
January
Nutraceuticals
1xbet 모바일 Enters into Health Promotion Partnership with Chiba Prefecture
Nutraceuticals
Blocks both Ultraviolet and Near 1xbet 모바일frared Radiation Announc1xbet 모바일g New 1xbet 모바일nerSignal UV+IR Protect Makeup Base
1xbet 모바일s
1xbet 모바일 Files a Supplemental Application in Japan: A Plastic Case with Anti-Stroke Medicine for a Smart Medicine Container
Nutraceuticals
Hokkaido University and 1xbet 모바일 to Collaborate in Joint Research(PDF: 213.0 KB)
Nutraceuticals
1xbet 모바일 Enters Into Health Promotion Partnership with Shimane Prefecture
1xbet 모바일s
1xbet 모바일 Launches a New Treatment for Glaucoma and Ocular Hypertension - Mikeluna®Comb1xbet 모바일ation Ophthalmic Solution 1xbet 모바일 Japan
1xbet 모바일s